LOINC
Version 2.67

76397-9Lymph node involvementActive

Term Description

Patients are allocated into two risk groups based on lymph node involvement; the risk group for node-negative patients, and the risk group for node-positive (1-3) patients. This term was created for, but not limited in use to, the Prosigna Breast Cancer Prognostic Gene Signature assay, which is based on the reported 50-gene classifier algorithm originally named PAM50.
Source: Regenstrief LOINC

Fully-Specified Name

Component
Lymph node involvement
Property
Find
Time
Pt
System
Lymph node
Scale
Ord
Method

Additional Names

Short Name
LN involved LN Ql
Display Name
Lymph node involvement Ql (Lymph node)

Basic Attributes

Class
PATH
Type
Laboratory
First Released
Version 2.52
Last Updated
Version 2.58
Order vs. Observation
Observation

Example Answer List LL3177-4

Source: Laboratory Corporation of America

Answer Code Score Answer ID
Lymph node negative LA21989-1
Lymph node positive (1-3 positive nodes) LA21990-9

Member of these Panels

LOINC Long Common Name
76546-1 Breast cancer 10-year risk of distant recurrence panel by Prosigna

Language Variants Get Info

zh-CNChinese (CHINA)
淋巴结累及:发现:时间点:淋巴结:序数型:
fr-FRFrench (FRANCE)
Lymph node involvement:Find:Pt:Lymph node:Ord:
it-ITItalian (ITALY)
Interessamento del linfonodo:Osservazione:Pt:Linfonodo:Ord:
es-ESSpanish (SPAIN)
Afectación de ganglios linfáticos:Hallazgo:Punto temporal:Nodo linfático:Ord:

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=76397-9